Study: Lethal Dose of Bupivacaine Higher for Rats 2 vs. 16 Weeks Old

The lethal dose for racemic bupivacaine was higher for two-week-old rats than for 16-week-old rats, according to a study published in Anesthesia & Analgesia.

Advertisement

Researchers infused Wistar rats with RS(±)-bupivacaine and S(−)-bupivacaine and tested cardiac electrical activity, cardiac muscle contraction and Ca2+ regulation. They found that the lethal dose of bupivacaine and strength of muscle twitches were higher in 2-week-old rats compared to 16-week-old rats. In addition, 2-week-old rats had a higher increase in Ca2+ release from the sarcoplasmic reticulum preactivated with caffeine than did their older counterparts.

The authors suggest that different mechanisms for intracellular SR Ca2+ regulation in younger rats may partially account for their decreased susceptibility to cardiodepression from bupivacaine.

Read the Anesthesia & Analgesia abstract on bupivacaine-induced cardiotoxicity at different ages.

Read more coverage on anesthesia:

Society of Anesthesia and Sleep Medicine Encourages Anesthesiologists to Become ‘Perioperative Sleep Physicians’

ASA Provides Information on Radiation Exposure, Relief Efforts in Japan

FDA Grants Official Approval for Appeal of Sedasys System

Advertisement

Next Up in Anesthesia

  • Here are three health systems that have lost or cut ties with their anesthesia providers this year:  1. Des Moines,…

  • Des Moines, Iowa-based MercyOne Medical Center has ended its partnership with anesthesia services provider, Medical Center Anesthesiologists, according to a…

Advertisement

Comments are closed.